Key result
Higher preoperative walking distance is linked to ~12% lower post-LVAD mortality per 50 m increase.
Why the study?
Accurate preoperative risk stratification in advanced heart failure before durable LVAD implantation remains challenging, motivating evaluation of preoperative 6MWD and its discriminative ability compared with peak oxygen uptake.
Does preoperative six-minute walk distance predict all-cause mortality and improve risk discrimination compared with peak oxygen uptake in patients with advanced heart failure undergoing durable left ventricular assist device implantation?
Cohort (n=136)
No
Does preoperative six-minute walk distance predict all-cause mortality and improve risk discrimination compared with peak oxygen uptake in patients with advanced heart failure undergoing durable left ventricular assist device implantation?
Preoperative six-minute walk distance is an independent predictor of all-cause mortality after durable LVAD implantation with prognostic discrimination comparable to peak oxygen uptake.
Answers are grounded in this paper and cite their sources.
Preoperative 6MWD may refine mortality risk stratification before LVAD; hypothesis-generating and requires prospective validation.
Accurate preoperative risk stratification remains a challenge in advanced heart failure before durable left ventricular assist device (LVAD) implantation. We assessed whether preoperative six-minute walk distance (6MWD) was associated with all-cause mortality and compared its discrimination with peak oxygen uptake (pVO 2 ). In this retrospective single-center cohort (January 2016–May 2025), 136 of 206 implanted patients had an eligible preoperative 6MWD. Deaths through May 29, 2026, were ascertained from recorded death dates. During follow-up, 85 patients died; median observed follow-up was 871.5 days. The area under the receiver operating characteristic curve was 0.712 for 6MWD (n = 136) and 0.639 for pVO 2 (n = 127); paired comparison in 127 patients showed no significant difference (DeLong p = 0.212). Each 50 m increase in 6MWD was associated with lower mortality (hazard ratio [HR]: 0.88, 95% confidence interval [CI]: 0.79–0.98). Patients walking less than 350 m had worse survival (log-rank p = 0.002; HR: 1.98, 95% CI: 1.27–3.11). The association persisted after adjustment for age, INTERMACS profile, and device type (HR: 2.12, 95% CI: 1.27–3.54). Preoperative 6MWD may contribute to risk stratification before durable LVAD implantation; the threshold requires external validation.
No takes yet. Share an insight, caveat, or question.
Karapolat et al. (2026) conducted a cohort in Advanced heart failure undergoing durable left ventricular assist device (LVAD) implantation (n=136). Preoperative six-minute walk distance (6MWD) vs. Peak oxygen uptake (pVO2) and 6MWD ≥350 m was evaluated on All-cause mortality (HR 0.88 per 50 m increase (adjusted HR 2.12 for <350 m), 95% CI 0.79-0.98, p=0.002). Preoperative walking distance <350 m was associated with higher all-cause mortality after durable LVAD implantation, with each 50 m increase lowering risk.
Synapse has enriched 10 related papers. Consider them for comparative context: